Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
14.63 USD | +6.87% | +13.34% | -32.58% |
04-25 | Truist Securities Cuts Sage Therapeutics' Price Target to $18 From $22, Hold Rating Maintained | MT |
04-25 | Transcript : Sage Therapeutics, Inc., Q1 2024 Earnings Call, Apr 25, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.58% | 824M | |
-2.38% | 103B | |
+1.87% | 95.28B | |
+1.46% | 22.15B | |
-15.57% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-12.91% | 16.05B | |
+5.31% | 13.68B | |
+35.38% | 12.17B |
- Stock Market
- Equities
- SAGE Stock
- News Sage Therapeutics, Inc.
- Berenberg Bank Initiates Sage Therapeutics at Hold With $37 Price Target